Latest News - Fillers & Injectables

Thursday, October 12, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates, Galderma

FDA Approves Injection of Restylane Silk via Cannula for Lip Augmentation

The FDA has approved the use of a small blunt tip cannula with Galderma's Restylane Silk for lip augmentation. Restylane Silk was the first FDA-approved hyaluronic acid (HA) dermal filler specific…

Read the full story

Monday, October 09, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, American Society for Dermatologic Surgery

And the ASDS Stegman Award Goes to … Susan H. Weinkle, MD

Bradenton, FL-based dermatologist Susan H. Weinkle, MD received the Samuel J. Stegman, MD, Award for Distinguished Service at The American Society for Dermatologic Surgery (ASDS) 2017 Annual Meet…

Read the full story

Friday, October 06, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, American Society for Dermatologic Surgery

Lisa M. Donofrio, MD Takes Reins of ASDS/ASDSA

Lisa M. Donofrio, MD, is the new President of the American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA). Along with her fellow officers …

Read the full story

Tuesday, September 12, 2017 | Personnel/Company News, PracticalDermatology.com, Product Launches and Updates, Allergan , SkinMedica, Zeltiq

Allergan Adds Coolsculpting, Other Bells and Whistles to Brilliant Distinctions® Patient Loyalty Program

Allergan is launching the next generation of its U.S.-based Brilliant Distinctions® program. The new offering incorporates digital innovation to enhance the consumer experience and drive increa…

Read the full story

Friday, September 08, 2017 | Personnel/Company News, PracticalDermatology.com, Allergan

Deion Sanders Named Brand Ambassador for Botox Cosmetic

NFL analyst and philanthropist Deion Sanders, the only athlete to play in both the Super Bowl™ and World Series™, is the new brand ambassador for BOTOX® Cosmetic. Allergan…

Read the full story

Thursday, September 07, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, Galderma

Galderma Names New Managers of Prescription Business and Aesthetic & Corrective Business Units; Dr. Kelly Huang to Obalon

Galdmera has named new managers of its Prescription Business and Aesthetic & Corrective Business units in the United States. Chris Chapman is Galderma’s new Vice President and General Manage…

Read the full story

Wednesday, August 09, 2017 | PracticalDermatology.com, Product Launches and Updates, Research and Publications

Bonti’s Novel Gateway Neuromodulator Performs Well in Phase 2A Study

Bonti’s lead product candidate, EB- 001, passed muster in a Phase 2A study for the treatment of glabellar lines. EB-001 is a novel serotype E botulinum neurotoxin with a unique efficacy profi…

Read the full story

Wednesday, July 12, 2017 | Personnel/Company News, PracticalDermatology.com, Allergan

Allergan CEO: Consensus Needed on Medical Aesthetic Treatment in Minors

Allergan Chairman & CEO Brent Saunders, the father of two high school-aged girls, is speaking up and out about the risks associated with offering medical aesthetic treatments to minors. In a ne…

Read the full story

Tuesday, June 27, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications, American Society for Dermatologic Surgery

ASDS: Percentage of Us Wanting Cosmetic Surgery Doubled Since 2013

Nearly 70 percent of consumers now say they are thinking about getting a cosmetic treatment, according to survey data released by the American Society for Dermatologic Surgery (ASDS). The ASDS Cons…

Read the full story

Monday, June 26, 2017 | PracticalDermatology.com

Thumbs Down for Neothetics, Inc.’s LIPO-202; Stock Plummets

Neothetics, Inc.’s LIPO-202 for the reduction of submental subcutaneous fat failed to demonstrate improvement on any efficacy measurements or separation from placebo in a Phase 2 proof-of-c…

Read the full story

Tuesday, May 30, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, American Society for Dermatologic Surgery

ASDS: Nearly 10.5 Million Treatments Performed in 2016

Dermatologic surgeons performed nearly 10.5 million medically necessary and cosmetic procedures in 2016 -- five percent more than 2015 and up 31 percent since 2012, according to the 2016 American So…

Read the full story

Thursday, April 06, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Galderma

Phase 4 Studies of Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefit

Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that…

Read the full story

Monday, March 20, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Allergan

FDA Approved Juvéderm Vollure XC for Correction of Facial Wrinkles and Folds

The FDA has approved Allergan plc's Juvéderm Vollure XC for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21. In the US piv…

Read the full story

Tuesday, March 14, 2017 | PracticalDermatology.com, Allergan

Survey Findings: Submental Region Major Pain Point for Patients

Close to 50 percent of individuals are bothered by the appearance of the area under their chin, and many alter their behavior as a result, according to a new survey commissioned by Allergan plc. …

Read the full story

Thursday, March 02, 2017 | PracticalDermatology.com, Product Launches and Updates, Galderma

Galderma Moves to Differentiate Their Two New HA Fillers From The Fray

With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --Restylane Refyne and Restylane Defyne  --stand o…

Read the full story
Load More